Taysha Gene Therapies
TSHA
#5674
Rank
โ‚น111.73 B
Marketcap
โ‚น407.91
Share price
-3.97%
Change (1 day)
175.54%
Change (1 year)

Market capitalization of Taysha Gene Therapies (TSHA)

Market cap: โ‚น111.73 Billion

As of February 2026 Taysha Gene Therapies has a market cap of โ‚น111.73 Billion. This makes Taysha Gene Therapies the world's 5674th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Taysha Gene Therapies from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น111.73 B-22.06%
2025โ‚น143.35 B365.94%
2024โ‚น30.76 B11.68%
2023โ‚น27.54 B135.91%
2022โ‚น11.67 B-65%
2021โ‚น33.36 B-54.48%
2020โ‚น73.29 B

End of Day market cap according to different sources

On Feb 25th, 2026 the market cap of Taysha Gene Therapies was reported to be:

โ‚น116.34 Billion
by Nasdaq info icon info icon
โ‚น116.34 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
โ‚น113.64 B 1.71%๐Ÿ‡บ๐Ÿ‡ธ USA